A clinical study to investigate the effect of rosiglitazone, theophylline and inhaled corticosteroid, inflammation and pulmonary function in asthmatic smokers.
Phase of Trial: Phase II/III
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Rosiglitazone (Primary) ; Theophylline (Primary) ; Beclometasone
- Indications Asthma
- Focus Therapeutic Use
- 19 Mar 2008 Additional trial identifier EudraCT2004-004247-22 added as reported by ClinicalTrials.gov.
- 08 Nov 2007 Status changed from in progress to completed as reported on clinicaltrials.gov website.
- 24 Dec 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History